Trial NCT00369551

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2012-02718
Secondary IDs: 14576A 7213 CDR0000491998 N01CM62201 NCI-2012-02718 NCI-7213 P30CA014599 UCCRC-14576A

Last trial update was posted on 2014-03-06

MeSH Interventions

Antibodies Antibodies, Monoclonal Antineoplastic Agents, Immunological Bevacizumab Carboplatin Immunoglobulins Paclitaxel

MeSH Conditions

Adenocarcinoma of Lung Adenocarcinoma, Bronchiolo-Alveolar Carcinoma, Non-Small-Cell Lung Lung Neoplasms

Other Conditions

Adenocarcinoma of the Lung Bronchoalveolar Cell Lung Cancer Large Cell Lung Cancer Stage II Non-small Cell Lung Cancer Stage IIIA Non-small Cell Lung Cancer Stage IIIB Non-small Cell Lung Cancer

Stopping Reasons

N/A

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID